Name | Title | Contact Details |
---|
XORTX Therapeutics Inc. is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. XORTX has lead programs to develop treatments for progressive kidney disease due to diabetes, diabetic nephropathy, and polycystic kidney disease. Secondary programs focus on developing therapies for health consequences that accompany pre-diabetes, diabetes and cardiovascular disease.
Innodia Inc. is a Laval, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Meda is a Somerset, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Virdante Pharmaceuticals, Inc. is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.